Future Management of Waldenstrom Macroglobulinemia
Watch
BTK Inhibitors in WM: Understanding Safety/Efficacy
Targeted Approaches in Waldenstrom Macroglobulinemia
Selecting Therapy Through Multiple Lines in WM
Waldenstrom Macroglobulinemia: Evolving Frontline Treatment
A Historic Perspective on Frontline WM Management
Waldenstrom Macroglobulinemia: When to Initiate Therapy
Factors Impacting a Diagnosis and Prognosis of WM
Waldenstrom Macroglobulinemia: Establishing a Diagnosis
Risk Factors in Developing Waldenstrom Macroglobulinemia
The Nature of Waldenstrom Macroglobulinemia
Immunotherapy Side Effects: Know the Risks
Immunotherapy can cause some side effects that patients and practitioners should look out for.
Immunotherapy Pair Good for Some, Not All, With Kidney Cancer
Yervoy plus Opdivo is a good combination for many patients with kidney cancer, though some individuals should steer clear of the regimen.
Turning Love for Family Into Cancer Research
After her daughter was diagnosed, Celia Miltz founded the Friends of ET Research.
Expert Discusses Exciting Advances in the MPN Field
Angela Fleischman, M.D., Ph.D., is particularly excited for improvements in treating early-stage disease.
A PSA for Myeloproliferative Neoplasms
After realizing how little awareness there was about MPNs, one advocate looked to his TV background to help.
A Cure Is Needed for MPNs, says 12-Year-Old
Jaden Persaud knows firsthand how a MPN diagnosis can affect a family's life.
Insight on Novel Therapies in Follicular Lymphoma
Practical Advice for Patients With Newly Diagnosed FL
Multidisciplinary Management of Follicular Lymphoma
Preparing Patients for PI3K Infusion-Based Therapy
Managing Gerald Through a Relapse of Follicular Lymphoma
Gerald's Journey Through Follicular Lymphoma
Considerations in the Diagnosis of Follicular Lymphoma
Early Treatment for Myelodysplastic Syndrome: Many Patients Are Missing Out
Many patients with myelodysplastic syndrome are not receiving early treatment.
It's an Exciting Time for Myelodysplastic Syndrome
Learning more about MDS will lead to better diagnostics and more personalized treatments.
Cure: Is it Possible for CLL?
Will the word "cure" be used for patients with chronic lymphocytic leukemia (CLL)?
Not the 'Typical Cancer Patient'
Katherine Heinowitz said she had the best year of her life after being diagnosed with cancer. But to do that, she had to do something she had never done before.
Knowledge Is Key in Patient Advocacy
Understanding the disease and treatments are key aspects of being a patient advocate, explained MPN Hero Marcy Worthington.
Physician Turns Personal Diagnosis to Educational Opportunity
Brian Koffman is a family physician who used his own CLL diagnosis to start a group that informs other patients and their loved ones.
